Fibrinolytic treatment with tissue plasminogen activator. Outcomes in clinical practice with a multidisciplinary model of intervention;Tratamiento fibrinolítico con activador del plasminógeno tisular. Resultados en la práctica clínica con un modelo de actuación multidisciplinario

Revista de Neurologia

Volumn 45, Issue 3, 2007, Pages 129-133

  Martínez Pérez, Melcior ^a   Canovas Verge D ^a   Carvajal Diaz A ^b  

^a HOSPITAL DE SABADELL   (Spain)

^b Hospital Universitari Parc Taulí   (Spain)

Author keywords

Acute cerebral ischaemia; Intravenous thrombolysis; Multidisciplinary protocol; SITS MOST; Stroke code; Tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITAL; HUMAN; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RANKIN SCALE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 37349039030     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4503.2007217     Document Type: Article

References (18)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
2. Adams HP Jr, Adams RJ, Brott TH, Del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischaemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056-83.
3. Hack W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, et al, European Stroke Initiative Executive Committee and the EUSI Writing Committee. European stroke initiative recommendations for stroke management -update 2003. Cerebrovasc Dis 2003; 16: 311-37.
4. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet 2007; 369: 275-82.
5. Safe Implementation of Thrombolysis in Stroke: a Multinational Multicentre Monitoring Study of Safety and Efficacy on Thrombolysis in Stroke. URL: http//www.acutestroke.org.
6. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 2220-6.
7. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and realibility of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-4.
8. Teasdale G, Jenett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2: 81-4.
9. Hacke W, Kaste M, Frieschi C, Toni D, Lesaffre E, Von Kummer R, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-51.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
11. Bonita R, Beaglehole R. Modification of Rankin scale: recovery of motor function after stroke. Stroke 1988; 19: 1497-500.
12. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
13. Berger CH, Fiorelli M, Steiner TH, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue. Asymptomatic or symptomatic? Stroke 2001; 32: 1330-5.
14. Molina C, Álvarez-Sabín J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, et al. Thrombolysis-related hemorrhagic infarction. A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002; 33: 1551-6.
15. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA 2004; 292: 1831-8.
16. Dávalos A, Álvarez-Sabín J, Martí-Vilalta JL, Castillo J, por el Registro de Trombólisis del Grupo de Estudio de las Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Proyecto ICTUS. Tratamiento intravenoso con activador del plasminógeno tisular en la isquemia cerebral aguda. Med Clin (Barc) 2003; 120: 1-5.
17. Masjuán J, De Leciñana MA, García N, Zarza B, Díaz M, Martínez JC, et al. Tratamiento trombolítico del ictus isquémico agudo en un centro sin experiencia previa. Desarrollo de la organización interna y primeros resultados. Rev Clin Esp 2006; 206: 485-90.
18. Akins PT, Delemos C, Wentworth RN, Byer J, Schorer SJ, Atkinson RP. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology 2000; 55: 1801-5.